Evaluation of IL-29 in Euthyroid Patients with Graves’ Orbitopathy: A Preliminary Study
Background. The most frequent cause of hyperthyroidism is Graves’ disease (GD). Orbitopathy is the most prevalent and recognizable extrathyroidal manifestation of Graves’ disease with unrevealed pathogenesis. Interleukin 29 (IL-29) is a relatively newly discovered inflammatory cytokine. Thus, the ai...
Saved in:
Main Authors: | Bogusz Falkowski, Ewelina Szczepanek-Parulska, Nadia Sawicka-Gutaj, Aleksandra Krygier, Marek Ruchala |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/4748612 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IgG4 as a Biomarker in Graves’ Orbitopathy
by: Michał Olejarz, et al.
Published: (2021-01-01) -
The Influence of Prior Hyperthyroidism on Euthyroid Graves’ Ophthalmopathy
by: Karolien Termote, et al.
Published: (2014-01-01) -
Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves’ Orbitopathy
by: Piotr Miśkiewicz, et al.
Published: (2018-01-01) -
Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves’ Orbitopathy
by: Chao Ma, et al.
Published: (2022-01-01) -
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
by: Hiroyuki Eguchi, et al.
Published: (2015-01-01)